Genetic risk variants associated with in situ breast cancer.

Breast Cancer Res 2015 Jun 13;17:82. Epub 2015 Jun 13.

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120, Heidelberg, Germany.

Introduction: Breast cancer in situ (BCIS) diagnoses, a precursor lesion for invasive breast cancer, comprise about 20 % of all breast cancers (BC) in countries with screening programs. Family history of BC is considered one of the strongest risk factors for BCIS.

Methods: To evaluate the association of BC susceptibility loci with BCIS risk, we genotyped 39 single nucleotide polymorphisms (SNPs), associated with risk of invasive BC, in 1317 BCIS cases, 10,645 invasive BC cases, and 14,006 healthy controls in the National Cancer Institute's Breast and Prostate Cancer Cohort Consortium (BPC3). Using unconditional logistic regression models adjusted for age and study, we estimated the association of SNPs with BCIS using two different comparison groups: healthy controls and invasive BC subjects to investigate whether BCIS and BC share a common genetic profile.

Results: We found that five SNPs (CDKN2BAS-rs1011970, FGFR2-rs3750817, FGFR2-rs2981582, TNRC9-rs3803662, 5p12-rs10941679) were significantly associated with BCIS risk (P value adjusted for multiple comparisons <0.0016). Comparing invasive BC and BCIS, the largest difference was for CDKN2BAS-rs1011970, which showed a positive association with BCIS (OR = 1.24, 95 % CI: 1.11-1.38, P = 1.27 x 10(-4)) and no association with invasive BC (OR = 1.03, 95 % CI: 0.99-1.07, P = 0.06), with a P value for case-case comparison of 0.006. Subgroup analyses investigating associations with ductal carcinoma in situ (DCIS) found similar associations, albeit less significant (OR = 1.25, 95 % CI: 1.09-1.42, P = 1.07 x 10(-3)). Additional risk analyses showed significant associations with invasive disease at the 0.05 level for 28 of the alleles and the OR estimates were consistent with those reported by other studies.

Conclusions: Our study adds to the knowledge that several of the known BC susceptibility loci are risk factors for both BCIS and invasive BC, with the possible exception of rs1011970, a putatively functional SNP situated in the CDKN2BAS gene that may be a specific BCIS susceptibility locus.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-015-0596-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487950PMC
June 2015
19 Reads

Publication Analysis

Top Keywords

breast cancer
12
bcis risk
8
healthy controls
8
bcis
6
cancer
5
breast
5
institute's breast
4
breast prostate
4
cancer institute's
4
controls national
4
national cancer
4
prostate cancer
4
cohort consortium
4
unconditional logistic
4
logistic regression
4
bpc3 unconditional
4
consortium bpc3
4
genotyped single
4
cancer cohort
4
cases 14006
4

References

(Supplied by CrossRef)
Article in BMJ.
NL Barnes et al.
BMJ. 2012
Article in Cancer.
PP Rosen et al.
Cancer. 1980
Article in Int J Cancer.
T To et al.
Int J Cancer. 2014
Article in Int J Cancer.
F Levi et al.
Int J Cancer. 2005
Article in Lancet Oncol.
JR Benson et al.
Lancet Oncol. 2013
Article in Cancer.
ME Sanders et al.
Cancer. 2005
Article in Oncology (Williston Park)
RA Smith et al.
Oncology (Williston Park) 2012
Article in Cancer J.
L Tabar et al.
Cancer J. 2003
Article in Curr Opin Obstet Gynecol.
V Cocquyt et al.
Curr Opin Obstet Gynecol. 2005
Article in J Natl Cancer Inst.
BA Virnig et al.
J Natl Cancer Inst. 2010
Article in Cancer Epidemiol Biomarkers Prev.
A Trentham-Dietz et al.
Cancer Epidemiol Biomarkers Prev. 2000

Similar Publications